Cellaviva Danmark June 7, 2021
Autism and Cerebral Palsy

Autism and Cerebral Palsy

Treatment with umbilical cord stem cells can significantly improve the function of children with CP injury and other neurological diseases.

Cellaviva Danmark March 22, 2021
Dr.dk writes about stem cell treatments

Dr.dk writes about stem cell treatments

Joshua Mark Brickman, professor at the University of Copenhagen says that the discovery of stem cells has had enormous meaning – the health service is in the middle of a revolution where in a few years we can treat diseases we did not have a chance of before.

Cellaviva Danmark February 9, 2021
Press release: Canadian Trial for ProTrans in COVID-19

Press release: Canadian Trial for ProTrans in COVID-19

Corona virus Canadian Trial for ProTrans in COVID-19 TUE, FEB 02, 2021 15:50 CET NextCell Pharma AB (“NextCell”) today announces that Health Canada and the McGill University Health Centre Research...

Cellaviva Danmark November 18, 2020
Stem cells in study against type 1 diabetes in children

Stem cells in study against type 1 diabetes in children

“The results of this cell therapy are very promising and it has now been shown to be effective in type 1 diabetes in a randomized, placebo-controlled study in adults. We hope to see the same positive effect in children”, says Per-Ola Carlsson, Chief Physician and Professor at Uppsala University Hospital / Uppsala University

Cellaviva Danmark October 23, 2020
Press release: ProTrans stem cells approved for clinical trials in COVID-19 patients

Press release: ProTrans stem cells approved for clinical trials in COVID-19 patients

Corona virus ProTrans for the treatment of patients with COVID-19 WED, OCT 21, 2020 17:00 CET NextCell Pharma AB ("NextCell") today announces that the application for clinical trial of COVID-19...

Cellaviva Danmark October 23, 2020
Allogeneic cell therapy has again shown an effect in type 1 diabetes

Allogeneic cell therapy has again shown an effect in type 1 diabetes

Type 1 diabetes ProTrans™, a drug candidate consisting of umbilical cord stem cells “Our vision is to improve treatment options for thousands, maybe millions of patients and reducing healthcare costs...

Cellaviva Danmark September 13, 2020
Rigshospitalet performs treatment with stem cells from the umbilical cord

Rigshospitalet performs treatment with stem cells from the umbilical cord

RIGSHOSPITALET Transplantation with stem cells from the umbilical cord is a treatment option for patients for whom we cannot find a suitable bone marrow donor. In Denmark, approx. 20% of...

Cellaviva Danmark September 8, 2020
Press release: ProTrans shows significant effect in Diabetes

Press release: ProTrans shows significant effect in Diabetes

Cellaviva's mother company NextCell Pharma AB ("NextCell") today announces that the ProTrans-2 clinical trial met the primary endpoint. Patients treated with a single dose ProTrans show a statistically significant improved...